Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death

Young Do Yoo, Young Min Chung, Jong Kuk Park, Chul Min Ahn, Sung Kyu Kim, Hyung Jung Kim

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)


Peroxiredoxin II (Prx II) is known not only to protect cells from oxidative damage caused by hydrogen peroxide (H2O2), but also to endow cancer cells with resistance to both H2O2 and cisplatin and to grant them radioresistance. In this study, we examined whether Prx II antisense could enhance cisplatin-induced cell death. When gastric cancer cells were transfected with various concentrations of Prx II antisense plasmid, pPrxII/AS, and then treated with the same concentrations of cisplatin, Prx II antisense enhanced cisplatin-induced cell death. The combination index (CI) at all doses of the combination was below 1, indicating that Prx II antisense sensitized cisplatin-induced cell death. This synergism was also observed in the cells transfected with a Prx II antisense oligomer. Our present results, therefore, suggest that Prx II antisense would be a very good sensitizer for cisplatin, and that Prx II as a target for chemosensitizers constitutes a promising avenue for future research.

Original languageEnglish
Pages (from-to)273-277
Number of pages5
JournalExperimental and Molecular Medicine
Issue number4
Publication statusPublished - 2002 Sept 30


  • Antisense
  • Chemosensitizer
  • Cisplatin
  • Multidrug resistance
  • Prx II

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry


Dive into the research topics of 'Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death'. Together they form a unique fingerprint.

Cite this